Jeff Drew | Chief Scientific Officer
Cells4Life Group LLP

Jeff Drew, Chief Scientific Officer, Cells4Life Group LLP

Dr Jeff Drew is the co-founder and a non-executive director of Cells4Life, a leading UK umbilical cord blood stem cell storage company. Jeff holds a degree in Microbiology and Virology from Manchester University, and a PhD in Molecular Virology from Reading University Institute of Animal Health at Pirbright, UK. Jeff has 22 years experience in microbiological, cancer, gene therapy and genetic research. His research has been conducted within various research institutes and departments at the UK including the Exotic Virus Research Laboratories at the Institute of Animal Health, Universities of Oxford, London, the Marie Curie Research Institute and the Chester Beatty Laboratories at the Institute of Cancer Research. 


Conference Day 1: Thursday 16th May 2019 @ 16:50

Toticyte – a revolution in cord blood processing

  • >99.5% haematocrit removal
  • At least 3x more viable stem cells at point of use than any other method
  • Maximum cell recoveries, even for small volumes
  • Primitive cell types retained
  • Clinically compatible
  • HTA authorised use, CE marked, ISO13485 certified
last published: 14/May/19 13:35 GMT

back to speakers

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.